Beckman Completes Hybritech Purchase
- Share via
FULLERTON — Beckman Instruments has completed its acquisition of San Diego-based Hybritech Inc., a diagnostics company, from Eli Lilly & Co. Terms were not disclosed.
Eli Lilly of Indianapolis said in September it was planning to sell Hybritech as part of Lilly’s plan to separate diagnostic and medical-devices businesses from its pharmaceutical operations. Beckman develops and manufactures automated systems and supplies for laboratories.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
